STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Amylyx Pharmaceuticals, Inc.
AMLX
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$1.28
-77.4%
Net Income/Share
$-4.43
-704.3%
Operating CF/Share
$-2.46
-1487.8%
Free CF/Share
$-2.46
-1650.6%
Cash/Share
$2.59
-53.1%
Book Value/Share
$2.42
-62.5%
Tangible Book/Share
$2.42
-62.5%
Equity/Share
$2.42
-62.5%
Interest Debt/Share
$0.03
-53.9%
Valuation
Market Cap
$257.58M
-74.0%
Enterprise Value
$182.17M
-77.9%
P/E Ratio
-0.85
-104.2%
P/S Ratio
2.95
+13.4%
P/OCF Ratio
-1.54
-101.9%
P/FCF Ratio
-1.53
-101.7%
P/B Ratio
1.56
-31.5%
P/TB Ratio
1.56
-31.5%
EV/Sales
2.08
-3.6%
EV/EBITDA
-0.63
-103.0%
Profitability
Earnings Yield
-117.15%
-2453.1%
FCF Yield
-65.15%
-6138.2%
ROE
-183.14%
-1711.0%
ROIC
-188.50%
-2443.1%
Return on Tangible Assets
-155.83%
-1736.6%
Capital Allocation
CapEx/OCF
-0.09%
-100.9%
CapEx/Revenue
0.18%
-44.9%
CapEx/Depreciation
0.17
-84.8%
SBC/Revenue
37.81%
+287.5%
Balance Sheet
Debt/Equity
0.01
+23.0%
Debt/Assets
0.01
+24.9%
Net Debt/EBITDA
0.26
+106.2%
Current Ratio
6.67
+17.7%
Interest Coverage
0.00x
Income Quality
0.56
+129.7%
Efficiency
Days Sales Outstanding
2 days
-95.1%
Days Payables Outstanding
25 days
-92.0%
Days Inventory
0 days
Receivables Turnover
195.46x
+1955.8%
Payables Turnover
14.34x
+1143.8%
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$2.17
-56.6%